期刊文献+

产β-内酰胺酶金黄色葡萄球菌的耐药性监测 被引量:4

Monitoring of Antimicrobial Resistance of Staphylococcus Aureus Strains Producing β-lactamase
下载PDF
导出
摘要 目的:探讨大理地区产β-内酰胺酶金黄色葡萄球菌的耐药情况。方法:采用VITEK-32型全自动微生物鉴定仪将葡萄球菌属鉴定到种,头孢硝噻吩滤纸片法检测β-内酰胺酶,药物敏感试验采用K-B法。结果:61株金黄色葡萄球菌中产β-内酰胺酶13株,产酶率21.3%,产酶株对万古霉素最敏感,其次为左氧氟沙星,对其他抗生素的耐药率前四位分别是氨苄西林92.4%,青霉素G92.4%,红霉素84.7%,克林霉素69.3%。结论:金黄色葡萄球菌的β内酰胺酶检测应作为常规项目开展,产β-内酰胺酶的金黄色葡萄球菌对青霉素类,大环内酯类抗生素高度耐药,万古霉素无耐药菌株,为首选药物,应在药敏试验指导下合理选用抗生素。 Objective: To investigate the characteristics of antimicrobial resistance of Staphylococcus aureus strains producing β-lactamase which were isolated from clinic in local hospitals. Methods: By using VITEK-32 automated microbiology system for identification of Staphylococcus, β- lactamase in Staphylococcus aureus was detected by Nitrocefin paper. Antimicrobial susceptibility was detected by the disk diffusion method. Results: Of 61 strains of Staphylococcus aurens, 13 strains produce β-1aetamase and the rate of producing enzymes was 21.3% .The strains producing enzymes were most sensitive to Vancomycin and more sensitive to Levofloxaein. The resistant rate of ampieillin and peneillin G were 92.4% and erythromycin was 84.7%; elindamyein was 69.3%. Conclusions: The detection of β- lactamase in Staphylococcus aureus must be a normal item. The strains producing β-lactamase were highly resistant to penicillins and macrolides. Vancomycin must he the first choice in anti-infection caused by Staphylococcus aureus. Antibiotics should be chosen rationally under the guide of the microbial sensitivity test.
出处 《大理学院学报(综合版)》 CAS 2010年第2期16-18,共3页 Journal of Dali University
基金 大理学院科研基金资助项目(2007X01)
关键词 金黄色葡萄球菌 Β内酰胺酶 耐药性监测 staphylococcus aureus β-lactamase drug resistance
  • 相关文献

参考文献10

二级参考文献38

共引文献413

同被引文献45

  • 1黄建生,张群智.临床感染标本的细菌谱及药敏分析[J].大理学院学报(综合版),2005,4(1):67-68. 被引量:2
  • 2董方,甄景慧,张美和.北京儿童医院ICU细菌流行分布及耐药性监测[J].首都医科大学学报,2005,26(3):353-356. 被引量:35
  • 3郑瑞强,林华,陈齐红,卢年芳,朱小平.综合性ICU医院感染细菌流行病学及耐药性分析[J].医学理论与实践,2007,20(4):484-486. 被引量:8
  • 4中华人民共和国卫生部医政司.全国临床检验操作规范[M].3版.南京:东南大学出版社,2006:164.
  • 5Steinberg JP,Clark CC,Hackman BO.Nasocomial and community-acquired Staphylococcus aureus bacteriemias from 1980 to1993·Impact of intravascular devices and methicillin resistance[J] .Clin InfectDis,1996,23(2):255.
  • 6NCCLS.Performance standard for antimicrobial susceptibilitytes-ting.fourteenth InformationalSuspplement(M-100-S14)[S] .2004.
  • 7Clinical and Laboratory Sandards Institute(CLSI).Perform-ance standards for antimicrobial susceptibility testing[S] .Sixteenth informational supplement.M100-S16.CLSI,2006:44-52.
  • 8Vasilieva E,Labischinski H,Berger-Bachi B.Identification and mapping of new chromosomal sites affecting response to beta-lactams in Staphylococcus aureus[J] .Antimirob Agents,1997,8(1):13.
  • 9KareivienE V,Pavilonis A,Sinkute G.Staphylococcusaureus resistance to antibiotics and spread of phage types[J] .Medicina(Kaunas),2006,42(4):332.
  • 10Li HX,Liu J,Wang FL,et al.A study on the development ofmechanism of drug resistance in Staphylococcus aureus[J] .Journalof Misdiagnostics,2008,8(33):8076.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部